SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-24-002874
Filing Date
2024-02-02
Accepted
2024-02-02 07:13:46
Documents
2
Period of Report
2024-01-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1442
2 shihpoa.htm EX-24 7280
  Complete submission text file 0001437749-24-002874.txt   10328
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1180 CELEBRATION BLVD, STE 103 CELEBRATION FL 34747
Business Address
Shih Alvin (Reporting) CIK: 0001610064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36913 | Film No.: 24588793